Skip to content

普雷西根生物

US · PGEN #2527 按市值排名 上市于 1970
6.39 -0.81 -11.26%
实时 - 追踪5344个代码 - 心跳于21秒前 · 2026-10-16 20:02

最新新闻

  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $18
    \u5e02\u573a\u8d44\u8baf · 2026/8/5
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $9
    \u5e02\u573a\u8d44\u8baf · 2025/11/14
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $10
    \u5e02\u573a\u8d44\u8baf · 2026/4/2
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $18
    \u5e02\u573a\u8d44\u8baf · 2026/10/1
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $6
    \u5e02\u573a\u8d44\u8baf · 2025/8/13
  • 评级变动
    Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $9
    \u5e02\u573a\u8d44\u8baf · 2026/3/26
  • 评级变动
    Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $8
    \u5e02\u573a\u8d44\u8baf · 2025/8/19
  • 评级变动
    J.P. Morgan Upgrades Precigen(PGEN.US) to Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2025/8/15
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $8.5
    \u5e02\u573a\u8d44\u8baf · 2025/8/15
  • H.C. Wainwright Keeps Their Buy Rating on Precigen (PGEN)
    TipRanks · 2026/10/1
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $10
    \u5e02\u573a\u8d44\u8baf · 2026/3/26
  • B. Riley Securities Initiates Precigen(PGEN.US) With Buy Rating, Announces Target Price $12
    \u5e02\u573a\u8d44\u8baf · 2026/9/25
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $14
    \u5e02\u573a\u8d44\u8baf · 2026/8/3
  • B. Riley Securities Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $12
    \u5e02\u573a\u8d44\u8baf · 2026/9/25
  • 评级变动
    Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $6
    \u5e02\u573a\u8d44\u8baf · 2025/6/13
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $11
    \u5e02\u573a\u8d44\u8baf · 2026/5/14
  • 评级变动
    Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $11
    \u5e02\u573a\u8d44\u8baf · 2026/5/14
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $8.5
    \u5e02\u573a\u8d44\u8baf · 2025/8/19
  • 评级变动
    H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $14
    \u5e02\u573a\u8d44\u8baf · 2026/5/28
  • 评级变动
    Cantor Fitzgerald Maintains Precigen(PGEN.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2025/9/26

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:02:22 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

普雷西根生物 讨论区 0 条评论

发表评论